nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2006-10-3-62-67nefr-631Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯORIGINAL ARTICLES. CLINICAL INVESTIGATIONSОЦЕНКА ТАКТИКИ ПРОВЕДЕНИЯ СЕАНСА ГЕМОДИАЛИЗА У БОЛЬНЫХ С РАЗНОЙ ВЕЛИЧИНОЙ АРТЕРИАЛЬНОГО ДАВЛЕНИЯASSESSMENT OF THE METHOD OF A HEMODIALYSIS PROCEDURE PERFORMED IN PATIENTS WITH DIFFERENT VALUES OF ARTERIAL PRESSUREБовкунИ. В.BovkunI. V.

кафедра пропедевтики

РумянцевА. Ш.RumyantsevA. Sh.

кафедра пропедевтики

Научно-исследовательский институт нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. ПавловаRussian Federation2006100320061036267Copyright © Бовкун И.В., Румянцев А.Ш., 20062006Бовкун И.В., Румянцев А.Ш.Bovkun I.V., Rumyantsev A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/631

ЦЕЛЬ ИССЛЕДОВАНИЯ – оценить правильность тактики проведения сеанса гемодиализа у больных с разной величиной артериального давления. ПАЦИЕНТЫ И МЕТОДЫ. Обследовали 95 больных, получающих лечение гемодиализом. Эффективность гемодиализа оценивали по степени редукции мочевины и критерию KT/V. Степень гидратации определяли при помощи биоимпедансометрии. РЕЗУЛЬТАТЫ. Лишь у половины пациентов отмечено нормальное систолическое АД. Нормальная степень гидратации выявлена у 33% больных. Однако тактика проведения сеанса ГД не отличалась в группах пациентов с пониженным, нормальным и повышенным систолическим артериальным давлением. В результате после сеанса ГД количество больных с гипотензией достоверно увеличилось. ЗАКЛЮЧЕНИЕ. Необходим индивидуальный подход при определении тактики сеанса ГД. Его можно достичь при определении степени гидратации инструментальными методами, такими, как биоимпедансометрия.

THE AIM of the investigation was to evaluate accuracy of performing the hemodialysis sessions in patients with different values of arterial pressure. PATIENTS AND METHODS. The effectiveness of hemodialysis performed in 95 patients was assessed by KT/V criterion and by the urea reduction ration. The degree of hydration was estimated by bioimpedansometry. RESULTS. Normal arterial pressure was revealed in half of our patients only. Only 33% of our patients had normal degree of hydration. But the strategy of hemodialysis was the same in patients with different arterial pressure. As a result, the number of hypotonic patients was considerably greater after hemodialysis. CONCLUSION. The strategy of hemodialysis sessions should be chosen individually that can be achieved using bioimpedansometry as a method of determination of the hydration degree.

гемодиализартериальная гипертензияартериальная гипотензиягипергидратациягипогидратациябиоимпедансометрияhemodialysisarterial hypertensionarterial hypotensionhyperhydrationhypohydrationbioimpedansometriaReferencesZoccali C. Cardiovascular risk in uraemic patients – is it fully explained by classical risk factors? Nephrol Dia Transplant 2000; 15: 454-457Zoccali C. Cardiovascular risk in uraemic patients – is it fully explained by classical risk factors? Nephrol Dia Transplant 2000; 15: 454-457Cohen EP. Hypertension in chronic hemodialysis: viewing a paradox, and some notes on therapy. Dial Transplant 2000; 29: 535-542Cohen EP. Hypertension in chronic hemodialysis: viewing a paradox, and some notes on therapy. Dial Transplant 2000; 29: 535-542Zoccali C, Mallamaci F, Tripepi G.Hypertension as a cardiovascular risk factor in end-stage renal failure. Curr Hypertens Rep 2002; 4(5): 381-386Zoccali C, Mallamaci F, Tripepi G.Hypertension as a cardiovascular risk factor in end-stage renal failure. Curr Hypertens Rep 2002; 4(5): 381-386Fernandez LM, Teruel JL, Quereda C. Predialysis arterial hypertension: risk factor for cardiovascular mortality during hemodialysis treatment. Nefrologia 2005; 25 [Suppl 4]: 23-27Fernandez LM, Teruel JL, Quereda C. Predialysis arterial hypertension: risk factor for cardiovascular mortality during hemodialysis treatment. Nefrologia 2005; 25 [Suppl 4]: 23-27Odar-Cederlof B, Kjellstrand CM. Cardiovasoactive peptides in hemodialysis patients: diagnostic tools and predictors of outcome: a review of present knowledge and future directions. Hemodial Int 2003; 7(3): 222-231Odar-Cederlof B, Kjellstrand CM. Cardiovasoactive peptides in hemodialysis patients: diagnostic tools and predictors of outcome: a review of present knowledge and future directions. Hemodial Int 2003; 7(3): 222-231Agarwal R. Management of hypertension in hemodialysis patients. Hemodial Int 2006; 10(3): 241-248Agarwal R. Management of hypertension in hemodialysis patients. Hemodial Int 2006; 10(3): 241-248Lopez-Gomez JM, Villaverde M, Jofre R. Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int 2005; 93 [Suppl 1]: S63-S68Lopez-Gomez JM, Villaverde M, Jofre R. Interdialytic weight gain as a marker of blood pressure, nutrition, and survival in hemodialysis patients. Kidney Int 2005; 93 [Suppl 1]: S63-S68Kovacic V, Roguljic L, Kovacic V. Ultrafiltration volume is associated with changes in blood pressure in chronically hemodialyzed patients. Ren Fail 2003; 25(6): 945-951Kovacic V, Roguljic L, Kovacic V. Ultrafiltration volume is associated with changes in blood pressure in chronically hemodialyzed patients. Ren Fail 2003; 25(6): 945-951Nesrallah G, Suri R, Moist L. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 2003; 42 [Suppl 1]: 13-17Nesrallah G, Suri R, Moist L. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis 2003; 42 [Suppl 1]: 13-17Grekas D, Kalevrosoglou I, Karamouzis M et al. Effect of sympathetic and plasma renin activity on hemodialysis hypertension. Clin Nephrol 2001;2: 115-120Grekas D, Kalevrosoglou I, Karamouzis M et al. Effect of sympathetic and plasma renin activity on hemodialysis hypertension. Clin Nephrol 2001;2: 115-120Visontai Z, Fulop D, Lenard Z. Carotid artery elasticity in hemodialysis-induced hypotension. Dialys and Transplant 2000; 6: 319-324Visontai Z, Fulop D, Lenard Z. Carotid artery elasticity in hemodialysis-induced hypotension. Dialys and Transplant 2000; 6: 319-324Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKT/V and ePCRn. Adv Ren Replace Ther 1995; 2 (4): 295-304Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKT/V and ePCRn. Adv Ren Replace Ther 1995; 2 (4): 295-304Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15(5): 458-482Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15(5): 458-482Barnas MGW, Boer WH, Koomans HA. Hamodynamische muster und spektralanalyse der Herzfrequenz-Veranderlichkeit wahrend Dialyse-Hypotension. Dialyse J 2000; 68: 97-108Barnas MGW, Boer WH, Koomans HA. Hamodynamische muster und spektralanalyse der Herzfrequenz-Veranderlichkeit wahrend Dialyse-Hypotension. Dialyse J 2000; 68: 97-108Landry DW, Oliver JA. Blood pressure instability during hemodialysis. Kidney Int 2006; 69(10):1710-1711Landry DW, Oliver JA. Blood pressure instability during hemodialysis. Kidney Int 2006; 69(10):1710-1711Takeda A, Toda T, Fujii T et al. Can predialysis hypertension prevent intradialytic hypotension in hemodialysis patients? Nephron Clin Pract 2006; 103(4): 137-143Takeda A, Toda T, Fujii T et al. Can predialysis hypertension prevent intradialytic hypotension in hemodialysis patients? Nephron Clin Pract 2006; 103(4): 137-143Katzarski KS, Divino Filho JC, Bergstrom J. Extracellular volume changes and blood pressure levels in hemodialysis patients. Hemodial Int 2003; 7(2): 135-142Katzarski KS, Divino Filho JC, Bergstrom J. Extracellular volume changes and blood pressure levels in hemodialysis patients. Hemodial Int 2003; 7(2): 135-142

The authors declare that there are no conflicts of interest present.